Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.74B
-
Number of holders
-
1950
-
Total 13F shares, excl. options
-
1.32B
-
Shares change
-
+26.4M
-
Total reported value, excl. options
-
$95.4B
-
Value change
-
+$1.9B
-
Put/Call ratio
-
0.54
-
Number of buys
-
734
-
Number of sells
-
-869
-
Price
-
$72.33
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q4 2018
2,100 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q4 2018.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,950 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.32B shares
of 1.74B outstanding shares and own 75.85% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (144M shares), Capital Research Global Investors (122M shares), BlackRock Inc. (121M shares), STATE STREET CORP (70.2M shares), WELLINGTON MANAGEMENT GROUP LLP (41.3M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (33.6M shares), NORTHERN TRUST CORP (26.6M shares), Bank of New York Mellon Corp (24.4M shares), FMR LLC (23.8M shares), and MORGAN STANLEY (23.2M shares).
This table shows the top 1950 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.